Rockwell Medical (RMTI) Change in Receivables (2010 - 2026)
Rockwell Medical (RMTI) posted Change in Receivables of $682000.0 for Q1 2026, up 1018.03% on a QoQ basis from $61000.0 in Q4 2025, and down 50.54% year-over-year from $1.4 million in Q1 2025.
Rockwell Medical (RMTI) Change in Receivables (2010 - 2026) Analysis & Trends
Rockwell Medical's Change in Receivables history runs 17 years deep, the most recent figure standing at $682000.0 for Q1 2026.
- Quarterly Change in Receivables fell 50.54% year-over-year to $682000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$599000.0 (up 57.94% YoY) and the FY2025 annual result came in at $98000.0, up 103.75% from the prior year.
- Change in Receivables was $682000.0 for Q1 2026 at Rockwell Medical, up from $61000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $4.0 million in Q3 2023 and bottomed at -$2.0 million in Q3 2024.
- A 5-year average of $185764.7 and a median of $61000.0 in 2025 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2022 — Change in Receivables tumbled 800.81% — and 2023, when it jumped 646.33%.
- Rockwell Medical's Change in Receivables stood at -$1.1 million in 2022, then surged by 238.99% to $1.5 million in 2023, then plunged by 138.05% to -$586000.0 in 2024, then soared by 110.41% to $61000.0 in 2025, then soared by 1018.03% to $682000.0 in 2026.
- Business Quant data shows RMTI's Change in Receivables at $682000.0 in Q1 2026, $61000.0 in Q4 2025, and $244000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -78.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 106.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -621.82 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -38.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 126.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 81.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn | 682,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 682,000.00 |
| Mar 31, 2026 | 682,000.00 |
| Dec 31, 2025 | 61,000.00 |
| Dec 31, 2025 | 61,000.00 |
| Sep 30, 2025 | 244,000.00 |
| Sep 30, 2025 | 244,000.00 |
| Jun 30, 2025 | -1.59 Mn |
| Jun 30, 2025 | -1.59 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | -586,000.00 |
| Dec 31, 2024 | -586,000.00 |
| Sep 30, 2024 | -1.96 Mn |
| Sep 30, 2024 | -1.96 Mn |
| Jun 30, 2024 | -254,000.00 |
| Jun 30, 2024 | -254,000.00 |
| Mar 31, 2024 | 193,000.00 |
| Mar 31, 2024 | 193,000.00 |
| Dec 31, 2023 | 1.54 Mn |
| Dec 31, 2023 | 1.54 Mn |